Truxton Phenobarbital Tablets 30mg Recall: Potential Label Mixup
Truxton recalls 30mg Phenobarbital Tablets due to potential mislabeling. Affected lots may have incorrect dosage information. Contact Truxton for details.
Lower-risk recall
Labeling: Label Mixup; potentially mislabeled
Contact the company
What happened, in plain English
Truxton is recalling 30mg Phenobarbital Tablets that may be mislabeled. This could lead to incorrect dosing if the label is wrong. Patients should check their bottle's lot number and contact Truxton for help. Read more at govinfonow.com/recall/41642-truxton-phenobarbital-tablets-30mg-recall-potential-label-mixup.
Source Summary by GovInfoNow · govinfonow.com/recall/41642-truxton-phenobarbital-tablets-30mg-recall-potential-label-mixup · Updated October 8, 2026 · FDA enforcement record: FDA #D-1112-2017
Cite this page
“Truxton Phenobarbital Tablets 30mg Recall: Potential Label Mixup.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41642-truxton-phenobarbital-tablets-30mg-recall-potential-label-mixup. Based on FDA recall #D-1112-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1112-2017%22&limit=1).
Why it’s dangerous
The tablets may have incorrect labeling, which could lead to wrong dosing. This is a potential mislabeling issue that might affect medication safety.
Who’s affected
Patients prescribed Phenobarbital Tablets by a doctor. Those with the specific lot numbers listed are most at risk.
How to tell if you have this one
Check for lot numbers: 70926A (exp. 11/17), 70981A (exp. 01/18), or H15A59 (exp. 08/18). The product is a 30mg Phenobarbital Tablets USP, 1000 count bottle.
- Brand
Truxton- Category
Drug
All 6 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Class |
|---|---|---|
| D-1111-2017 | Phenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6160-10; Lot # 70952A; Exp. 11/17 | Class I |
| D-1112-2017 | Phenobarbital Tablets USP, 30 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6145-10; Lot # 70926A; Exp. 11/17 Lot # 70981A; Exp. 01/18 Lot # H15A59; Exp. 08/18 | Class I |
| D-1113-2017 | Phenobarbital Tablets USP, 60 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6151-10; Lot # 71416A; Exp. 05/20 Lot # 70881A; Exp. 07/17 Lot # H15A68; Exp. 01/18 Lot # 70980A; Exp. 02/18 | Class II |
| D-1114-2017 | Phenobarbital Tablets USP, 100 mg, a) 100 count bottles (NDC 0463-6152-01), b) 1000 count bottles (NDC 0163-6152-10), Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031; a) Lot # 70989A; Exp. 02/18, Lot # 70973A; Exp. 01/18 b) Lot # 70973A; Exp. 01/18, Lot # H15A76; Exp. 02/18, Lot # 71346A; Exp. 12/19, Lot # 70989A; Exp. 02/18 | Class II |
| D-1115-2017 | Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10; Lot # C0260416A; Exp. 03/18 | Class II |
| D-1116-2017 | Phenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6160-10; Lot # 71162A; Exp. 10/18 Lot # 70915A; Exp. 08/17 Lot # H15A55; Exp. 11/17 | Class II |
What to do — step by step
Check Your Lot Number
Look for the lot number on the bottle: 70926A, 70981A, or H15A59.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1112-2017 (April 20, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1112-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.